NCT07205289View on ClinicalTrials.gov

Serum Collection Study for Assay Development

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

June 30, 2026

Conditions
Pneumococcal Disease, InvasivePneumococcal Disease
Interventions
BIOLOGICAL

Gamma-PN

Killed whole-cell pneumococcal vaccine

Trial Locations (1)

5000

RECRUITING

University of Adelaide Clinical Research Facility, Adelaide

Sponsors

Lead Sponsor

GPN Vaccines
All Listed Sponsors
lead

GPN Vaccines

INDUSTRY

NCT07205289 - Serum Collection Study for Assay Development | Biotech Hunter | Biotech Hunter